These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32772481)
21. Locoregional cutaneous metastases of malignant melanoma and their management. Wolf IH; Richtig E; Kopera D; Kerl H Dermatol Surg; 2004 Feb; 30(2 Pt 2):244-7. PubMed ID: 14871216 [TBL] [Abstract][Full Text] [Related]
22. Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Adams S; Kozhaya L; Martiniuk F; Meng TC; Chiriboga L; Liebes L; Hochman T; Shuman N; Axelrod D; Speyer J; Novik Y; Tiersten A; Goldberg JD; Formenti SC; Bhardwaj N; Unutmaz D; Demaria S Clin Cancer Res; 2012 Dec; 18(24):6748-57. PubMed ID: 22767669 [TBL] [Abstract][Full Text] [Related]
23. Using topical imiquimod for the management of positive in situ margins after melanoma resection. Pandit AS; Geiger EJ; Ariyan S; Narayan D; Choi JN Cancer Med; 2015 Apr; 4(4):507-12. PubMed ID: 25620351 [TBL] [Abstract][Full Text] [Related]
24. Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases. Mauldin IS; Wages NA; Stowman AM; Wang E; Olson WC; Deacon DH; Smith KT; Galeassi N; Teague JE; Smolkin ME; Chianese-Bullock KA; Clark RA; Petroni GR; Marincola FM; Mullins DW; Slingluff CL Cancer Immunol Immunother; 2016 Oct; 65(10):1201-12. PubMed ID: 27522582 [TBL] [Abstract][Full Text] [Related]
25. Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells. Savarese I; Papi F; D'Errico A; Gori A; Grazzini M; Vannucchi M; Massi D; De Giorgi V Clin Exp Dermatol; 2015 Jan; 40(1):27-30. PubMed ID: 25252087 [TBL] [Abstract][Full Text] [Related]
29. Topical imiquimod in the treatment of two cutaneous melanocytomas in a dog. Coyner K; Loeffler D Vet Dermatol; 2012 Apr; 23(2):145-9, e31. PubMed ID: 21777307 [TBL] [Abstract][Full Text] [Related]
30. Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer. Garcia-Mouronte E; Berna-Rico E; de Nicolas-Ruanes B; Azcarraga-Llobet C; Alonso-Martinez de Salinas L; Bea-Ardebol S Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446011 [TBL] [Abstract][Full Text] [Related]
31. [Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases]. Loquai C; Nashan D; Metze D; Beiteke U; Rüping KW; Luger TA; Grabbe S Hautarzt; 2004 Feb; 55(2):176-81. PubMed ID: 14968329 [TBL] [Abstract][Full Text] [Related]
32. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream. Ray CM; Kluk M; Grin CM; Grant-Kels JM Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545 [TBL] [Abstract][Full Text] [Related]
33. Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread. Ugurel S; Wagner A; Pföhler C; Tilgen W; Reinhold U Br J Dermatol; 2002 Sep; 147(3):621-4. PubMed ID: 12207622 [No Abstract] [Full Text] [Related]
34. Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod. Schön MP; Schön M Apoptosis; 2004 May; 9(3):291-8. PubMed ID: 15258460 [TBL] [Abstract][Full Text] [Related]
35. Progress of multiple cutaneous and subcutaneous melanoma metastases of the face during imiquimod treatment. Kowalzick L; Eickenscheidt L J Dtsch Dermatol Ges; 2009 Jun; 7(6):538-40. PubMed ID: 19298548 [TBL] [Abstract][Full Text] [Related]
37. Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases. Arbiser JL; Bips M; Seidler A; Bonner MY; Kovach C J Am Acad Dermatol; 2012 Aug; 67(2):e81-3. PubMed ID: 22794825 [No Abstract] [Full Text] [Related]
38. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars. Qiu Y; Ma G; Lin X; Jin Y; Chen H; Hu X Pediatr Dermatol; 2013; 30(3):342-7. PubMed ID: 23046440 [TBL] [Abstract][Full Text] [Related]
39. Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. Schön MP; Wienrich BG; Drewniok C; Bong AB; Eberle J; Geilen CC; Gollnick H; Schön M J Invest Dermatol; 2004 May; 122(5):1266-76. PubMed ID: 15140231 [TBL] [Abstract][Full Text] [Related]